News
HHS will drop buprenorphine waiver rule for most physicians
January 19, 2021
There were more than 83,000 deaths attributed to drug overdoses in the United States in the 12 months ending in June 2020.
News
Covert stroke after noncardiac surgery linked with cognitive decline
January 19, 2021
Does covert stroke increase the risk of cognitive decline after noncardiac surgery in patients older than 65 years?
News
Finding meaning in ‘Lean’?
January 15, 2021
Physician well-being should be included among quality improvement metrics for health systems.
News
Arthritis drugs ‘impressive’ for severe COVID but not ‘magic cure’
January 15, 2021
U.S. and U.K. experts weigh in on research that compares monoclonal antibody therapies with usual care for people critically ill with COVID-19.
News
Long-haul COVID-19 cases rise as stigma of chronic fatigue taunts
January 15, 2021
An estimated three-quarters of all patients with chronic fatigue syndrome report that their symptoms started after a viral infection.
News
The next likely COVID-19 vaccine has its advantages
January 15, 2021
A single Ad26.COV2.S dose was associated with S-binding and neutralizing antibodies in more than 90% of the participants.
News
DOACs show safety benefit in early stages of CKD
January 15, 2021
In terms of efficacy and bleeding risk, what is known about anticoagulation in patients with chronically impaired renal function?
News
COVID-19 symptoms persist months after acute infection
January 14, 2021
Majority of previously hospitalized patients were experiencing fatigue or muscle weakness 6 months after discharge.
News
CVD deaths rose, imaging declined during pandemic
January 14, 2021
Two new papers quantify the impact of COVID-19 on patients with heart disease: more deaths, less disease testing or diagnosis. Experts suggest shutdowns may have been too complete.
News
Eliminating hepatitis by 2030: HHS releases new strategic plan
January 14, 2021
The United States “is currently facing unprecedented hepatitis A outbreaks, while progress in preventing hepatitis B has stalled, and hepatitis C rates nearly tripled.”